These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 778655)

  • 21. Bromocryptine in levodopa response-losing parkinsonism. A double blind study.
    Jansen EN
    Eur Neurol; 1978; 17(2):92-9. PubMed ID: 344042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Idiopathic parkinsonism treated with bromocriptine.
    Teychenne PF; Leigh PN; Reid JL; Calne DB; Greenacre JK; Petrie A; Bamji AN
    Lancet; 1975 Sep; 2(7933):473-6. PubMed ID: 51285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lisuride in the treatment of Parkinsonism.
    Schachter M; Sheehy MP; Parkes JD; Marsden CD
    Acta Neurol Scand; 1980 Dec; 62(6):382-5. PubMed ID: 7468157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bromocriptine in Parkinson disease: further studies.
    Lieberman AN; Kupersmith M; Gopinathan G; Estey E; Goodgold A; Goldstein M
    Neurology; 1979 Mar; 29(3):363-9. PubMed ID: 571981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical studies with bromocriptine in idiopathic parkinsonism.
    Teychenne PF; Kartzinel R; Perlow M; Pfeiffer R; Calne DB
    Trans Am Neurol Assoc; 1976; 101():302-4. PubMed ID: 1037483
    [No Abstract]   [Full Text] [Related]  

  • 26. Bromocriptine in the treatment of advanced Parkinsonism.
    Kristensen O; Hansen E
    Acta Neurol Scand; 1977 Sep; 56(3):274-6. PubMed ID: 333856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies with bromocriptine: III. Concomitant administration of caffeine to patients with idiopathic parkinsonism.
    Kartzinel R; Shoulson I; Calne DB
    Neurology; 1976 Aug; 26(8):741-3. PubMed ID: 181692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of bromocriptine in the treatment of parkinsonism.
    Fahn S; Cote LJ; Snider SR; Barrett RE; Isgreen WP
    Neurology; 1979 Aug; 29(8):1077-83. PubMed ID: 572493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Letter: Efficacy of bromocriptine in 2 cases of levodopa-resistant parkinsonism].
    Kissel P; Andre JM; Jacquier A
    Nouv Presse Med; 1976 Jan; 5(4):210. PubMed ID: 1264671
    [No Abstract]   [Full Text] [Related]  

  • 30. [Letter: Effect of bromocryptine on the fluctuations following dopa therapy. On-off phenomenon in parkinsonian patients].
    Frattola L; Albizzati MG; Spano PF; Trabucchi M
    Nouv Presse Med; 1976 Aug 28-Sep 4; 5(28):1761. PubMed ID: 958891
    [No Abstract]   [Full Text] [Related]  

  • 31. Bromocriptine combined with levodopa in Parkinson's disease.
    Gauthier G; Martins da Silva A
    Eur Neurol; 1982; 21(4):217-26. PubMed ID: 7117308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lisuride in parkinsonism.
    Gopinathan G; Teräväinen H; Dambrosia JM; Ward CD; Sanes JN; Stuart WK; Evarts EV; Calne DB
    Neurology; 1981 Apr; 31(4):371-6. PubMed ID: 7194429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesulergine and bromocriptine in long-term treatment of advanced parkinsonism.
    Baas H; Schneider E; Fischer PA; Japp G
    J Neural Transm; 1985; 64(1):45-54. PubMed ID: 4067602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of Parkinson's disease with 8-alpha-amino-ergoline, CU 32-085.
    Schneider E; Hubener K; Fischer PA
    Neurology; 1983 Apr; 33(4):468-72. PubMed ID: 6682193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopa.
    Marsden CD
    Drugs; 1998; 55 Suppl 1():17-22. PubMed ID: 9483166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-year observation of mesulergine (CU 32-085) in advanced and newly treated parkinsonism.
    Schneider E; Baas H; Fischer PA; Japp G
    J Neurol; 1985; 232(1):24-8. PubMed ID: 3998771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of parkinsonian syndromes by bromocriptin].
    Gautier JC; Durand JP
    Nouv Presse Med; 1977 Jan; 6(3):171-4. PubMed ID: 319421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An ergot derivative in the treatment of Parkinson's disease.
    Calne DB; Shoulson I; Kartzinel R
    Postgrad Med J; 1976; 52suppl 1():81-5. PubMed ID: 183198
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trial.
    Gerlach J
    Acta Neurol Scand; 1976 Mar; 53(3):189-200. PubMed ID: 773080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term treatment of parkinsonism with bromocriptine.
    Calne DB; Plotkin C; Williams AC; Nutt JG; Neophytides A; Teychenne PF
    Lancet; 1978 Apr; 1(8067):735-8. PubMed ID: 76747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.